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Sheeppox virus (SPPV), a member of the Capripoxvirus genus of the Poxviridae, is the etiologic agent of a
significant disease of sheep in the developing world. Genomic analysis of pathogenic and vaccine capripoxvi-
ruses identified genes with potential roles in virulence and host range, including three genes with similarity to
kelch-like genes of other poxviruses and eukaryotes. Here, a mutant SPPV with a deletion in the SPPV-019
kelch-like gene, KLP, was derived from the pathogenic strain SPPV-SA. KLP exhibited in vitro growth
characteristics similar to those of SPPV-SA and revertant virus (RvKLP). KLP-infected cells exhibited a
reduction in Ca2-independent cell adhesion, suggesting that SPPV-019may modulate cellular adhesion. When
inoculated in sheep by the intranasal or intradermal routes, KLP was markedly attenuated, since all
KLP-infected lambs survived infection. In contrast, SPPV-SA and RvKLP induced mortality approaching
100%. Lambs inoculated with KLP exhibited marked reduction or delay in fever response, gross lesions,
viremia, and virus shedding compared to parental and revertant viruses. Together, these findings indicate that
SPPV-019 is a significant SPPV virulence determinant in sheep.
Sheeppox virus (SPPV) is the etiologic agent of a highly
significant disease of sheep and the type species of the genus
Capripoxvirus, one of the eight genera of the subfamily Chor-
dopoxvirinae of the Poxviridae (44). Other capripoxviruses
(CaPVs) include goatpox virus (GTPV) and lumpy skin disease
virus (LSDV), which cause disease in goats and cattle, respec-
tively. Due to their significant economic impact and potential
for disease transmission, CaPV diseases are listed diseases by
the World Organization for Animal Health (OIE).
Sheeppox is characterized by fever, ocular and nasal dis-
charges, papular dermatitis, and nodular lesions in a variety of
organs, including the lungs, trachea, and abomasum (6, 16).
Young animals are most susceptible, where mortality rates can
be as high as 50 to 70% (21, 26). Transmission of sheeppox is
thought to require close contact between animals and to occur
primarily via aerosol and respiratory droplet, though insect
vectors have also been implicated (21, 26, 33, 34). Sheeppox is
endemic throughout southwest and central Asia, the Indian
subcontinent, and African regions north of the equator (9, 16).
SPPV and other CaPVs are morphologically and serologi-
cally indistinguishable and genomically very similar, with over-
all conservation in genetic content and gene synteny and
96% nucleotide identity (7, 22, 32, 61). Comparison of field
and vaccine strains has shown that relatively few genomic
changes account for viral attenuation in CaPV. A number of
these genes are predicted to affect virulence and host range
(31, 61). Among the genes affected in vaccine strains of CaPV
were those with products similar to kelch-like proteins en-
coded by eukaryotes and other poxviruses.
Kelch-like proteins, including the prototype kelch encoded
by Drosophila, are members of a protein superfamily charac-
terized by the presence of kelch repeat motifs. These proteins
also belong to a subset of proteins characterized by a C-termi-
nal domain of multiple kelch repeats joined to a N-terminal
BTB/POZ (for broad-complex, tramtrack and bric-a`-brac/pox-
virus and zinc finger) domain via a BACK (for BTB and C-
terminal kelch) domain (1, 57, 58). Kelch-like proteins are
encoded by metazoans and demonstrate considerable expan-
sion in gene repertoire among vertebrates, with humans en-
coding more than 50 (48). Kelch-like proteins, whose BTB and
kelch domains can mediate protein-protein interactions, affect
multiple cellular processes, including cytoskeleton organiza-
tion and dynamics, ion channel modulation, transcriptional
regulation, and protein ubiquitination, where they serve as
substrate adapter proteins that mediate interaction between
ubiquitin ligase complexes and the substrates targeted for deg-
radation (1, 2, 14, 20, 49).
Kelch-like proteins are encoded by members of chordopox-
viral genera Orthopoxvirus, Capripoxvirus, Leporipoxvirus, Sui-
poxvirus, and Yatapoxvirus and by unassigned deerpox viruses.
Poxviral kelch-like genes are generally present as multiple,
divergent, and occasionally fragmented genes located in vari-
able and nonessential regions near genomic termini, leading to
the suggestion that they function in aspects of virus-host inter-
actions (55). Although domain structure is maintained, amino
acid identity between poxviral and cellular kelch-like proteins
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is low. Studies examining the role of poxviral kelch-like genes
in virus replication and pathogenesis have been limited to
orthopoxviruses, where deletion of single or multiple kelch-like
genes have been shown to affect lesion size, inflammatory cell
infiltration, or virulence in a mouse model or vascularization
and virus yield in a chorioallantoic membrane model of infec-
tion (4, 36, 47). These results have suggested a role for kelch-
like genes in poxvirus virulence and host range, perhaps
through the modulation of inflammatory responses (47). Still,
the role of individual kelch-like proteins in poxvirus virulence
remains to be fully elucidated.
SPPV encodes three kelch-like proteins—SPPV-019, SPPV-
144, and SPPV-151 (annotated as SPPV_16, SPPV_137, and
SPPV_144, respectively, in NCBI Reference Sequence acces-
sion NC_004002)—that exhibit 93 to 95% amino acid identity
to GTPV and LSDV orthologues (61). Examination of SPPV-
019 orthologues in GTPV G20 and LSDV Neethling vaccine
strains shows truncating frameshift mutations at positions 231
and 124, respectively, suggesting a role for CaPV SPPV-019-
like genes in virus virulence (31, 60). In the present study, we
examined the role of the kelch-like protein-encoding gene
SPPV-019 in sheep, the natural SPPV host. Our data indicate
that SPPV-019 markedly affects SPPV virulence after intrana-
sal or intradermal virus inoculation.
MATERIALS AND METHODS
Viruses and cell cultures. The pathogenic field isolate SPPV strain A (SPPV-
SA) was obtained from a sick sheep in the Almatinskaya region of Kazakhstan
and passaged nine times in sheep at the Scientific Research Agricultural Insti-
tute, Kazakhstan (61). Primary lamb kidney (LK) cells were obtained from the
Animal and Plant Health Inspection Service, U.S. Department of Agriculture, at
the Plum Island Animal Disease Center, Greenport, NY, and grown in Dulbecco
modified Eagle medium containing 10% fetal bovine serum and 50 g of gen-
tamicin/ml.
Construction of SPPV recombinant viruses TK, KLP, and its revertant
RvKLP. Recombinant SPPVs lacking the SPPV-019 kelch-like gene or the SPPV-
066 thymidine kinase gene (KLP and TK, respectively), a gene known to be
nonessential for capripoxvirus replication, were constructed (51, 63). Recombi-
nant SPPVs were generated by homologous recombination between parental
SPPV-SA and recombination transfer vectors containing appropriate gene de-
letions after viral infection (multiplicity of infection [MOI] of 10) and vector
transfection of LK cells (Lipofectamine 2000; Invitrogen, San Diego, CA) (65).
For vector construction, a cassette containing the Escherichia coli -glucuroni-
dase (GUS) gene downstream of a synthetic vaccinia virus (VACV) promoter
(VVp) (11) and flanked by viral sequences was PCR assembled according to
methods previously described (62). Briefly, VVp-GUS and 1 kbp each of
SPPV-019 or SPPV-066 flanking sequences were PCR amplified by using
primers that generate DNA fragments with overlapping ends. The fragments
were sequentially fused by recombinant PCR to generate the complete cas-
sette, which was cloned into the pCR2.1 vector (Invitrogen, San Diego, CA).
Primers included the following (5 to 3): GUS forward, TCCCTTATGTTA
CGTCCTGTAG; GUS reverse, TTCATTGTTTGCCTCCCTG; VVp for-
ward, CTAGCGATCGCGTTGCTGAAAAATTGAAATTTTATTTTTTTT
TTTTGG; VVp reverse, CTTTAAAATAAAAAAAAAAAACCTTATATTT
ATACAATGCAGGACATC; SPPV-019 left flank forward (S19Lf), CTAAA
TCATCATCAACAACTTCATTG; SPPV-019 left flank reverse (S19Lr), CA
GCAACGCGATCGCTACGTTATAGGAGCATTAGACATAGATAGTG;
SPPV-019 right flank forward (S19Rf) CTAAGCGGCCGCGTAAGTATTC
AAGATAATTAACAAAAAGTTG; SPPV-019 right flank reverse (S19Rr),
TAGATGATACGTATACGTGTGTGG; SPPV-066 left flank forward
(S66Lf), TTTATTTTACTCCTGTATTTATAGAACCTAC; SPPV-066 left
flank reverse (S66Lr), CAGCAACGCGATCGCTATAGGTCCTATAATTA
AATGTATATATCCATAG; SPPV-066 right flank forward (S66Rf), CTAA
GCGGCCGCGTAAGGCACTAGATAGCACATTTCAACG; and SPPV-
066 right flank reverse (S66Rr), TGTTGTCGTCCATCTATTAATATCC.
Primer pairs S19Lf/S19Rr and S66Lf/S66Rr were used to generate full-length
transfer cassettes. Primer pairs S19Tf (CTATGTCTAATGCTCCTATAACG
TTC)/S19Tr (TGTATAGTTAATAAAGTTGAAAGTTGGTC) and S66Tf
(ATGGACTATGGAT ATATACATTTAATTATAGTTCTA)/S66Tr (AAA
AATAACATTTCCTACAAAC) were used to test for the presence of SPPV-
019 and SPPV-066, respectively.
LK cell cultures were infected with harvested cell lysates from the infection-
transfection and overlaid with complete medium containing 0.5% SeaKem GTG
agarose (Cambrex Bioscience, Rockland, ME) and 5-bromo-4-chloro-3-indolyl
-D-glucuronic acid (X-Gluc). Blue plaques indicative of recombinant viruses
were collected and purified to homogeneity by additional plaque assays. Lack of
SPPV-019 or SPPV-066 gene sequences and the correct position and orientation
of reporter sequences in recombinant viruses were confirmed by PCR analysis. A
4-kbp genomic region flanking the deletion site was sequenced by using an
Applied Biosystems Prism 3730xl automated DNA sequencer (Applied Biosys-
tems, Foster City, CA).
A SPPV-019 revertant virus (RvKLP) was constructed by restoring SPPV-019
gene sequences to the KLP genome. A region of the SPPV-SA genome, in-
cluding the SPPV-019 gene and flanking regions, was PCR amplified using
primers S19Lf and S19Rr and cloned into pCR2.1. Isolated clones were se-
quenced using overlapping gene-specific primers. Transfer vectors with the cor-
rect SPPV sequences were used for RvKLP construction. In addition, a second
transfer vector, containing a single nucleotide insertion that introduced a stop
codon (amino acid 231) in the linker region between BTB/BACK and kelch-
repeat domains of SPPV-019, was used to create a second revertant virus, fsKLP.
LK cells were transfected with these transfer vectors and infected with KLP.
Harvested viruses were used to infect LK cells in 96-well plates, and supernatants
were assayed for the restoration of wild-type SPPV-019 sequences by dot blot
hybridization (protocol adapted from the method of Goswami and Glazer [24])
on a nylon membrane (Hoffmann-La Roche, Switzerland) using a SPPV-019-
specific digoxigenin-labeled probe generated with primer pair S19Tf/S19Tr (PCR
DIG probe synthesis kit; Hoffmann-La Roche). Positive wells were detected
using a DIG luminescence detection kit (Hoffmann-La Roche). RvKLP and
fsKLP virus clones were purified through two additional rounds of infection and
hybridization. A 5-kbp region extending 0.5 kbp outside of either end of the
original transfer cassette was then sequenced to ensure the integrity of SPPV-019
and adjacent genomic regions and to confirm the fsKLP sequence.
Ca2-independent cell adhesion assay. Ca2-independent cell adhesion was
assessed as previously described (47, 54), using the divalent cation chelator
EDTA instead of EGTA. LK cells grown on chamber slides (Nunc, Inc., Naper-
ville, IL) were either mock infected or infected with SPPV-SA, KLP, or RvKLP
viruses (MOI of 10) and allowed to incubate for 24 h. Cells were then washed
with phosphate-buffered saline (PBS), treated with 0.1 mM EDTA, and moni-
tored at 5-min intervals for cell adhesion using an inverted microscope and an
attached Nikon CoolPix 5000 digital camera. The results were obtained from
three independent experiments, and the percent rounded cells was calculated
from three randomly selected fields per time point.
Animal inoculation. Three- to four-month-old Merino lambs were inoculated
intranasally with 106 PFU of the SPPV-SA, KLP, TK, or RvKLP viruses/
animal. Clinical signs of sheeppox, including fever (a rectal temperature equal to
or greater than 39.7°C), anorexia, lethargy, nasal and ocular discharges, cough-
ing, labored respiration, recumbency, and the appearance of skin lesions, were
monitored daily. Blood samples and nasal swabs were collected every day for the
first 10 days and every other day thereafter for the duration of the 30-day
experiment. Lambs were euthanized when found moribund or at the end of the
experiment, and tissue samples were collected. Tissue samples were immediately
frozen at 70°C for virus isolation and titration or fixed in 10% neutral buffered
formalin for histopathology. Frozen tissues were weighed, homogenized and
clarified by low-speed centrifugation. Virus isolation from clinical samples was
performed with LK cells as described in OIE protocols (http://www.oie.int/eng
/normes/mmanual/A_00033.htm). Virus titration in buffy coat and tissue homog-
enates was performed by the limiting-dilution method. Titers were calculated by
the method of Spearman-Karber and are expressed as the 50% tissue culture
infectious dose (TCID50) (18).
Additional lambs were intradermally inoculated in the left flank and inner side
of the left thigh with 104 PFU of SPPV-SA, KLP, or fsKLP virus or mock
infected with PBS. Lambs were monitored and sampled as described above and
then euthanized and necropsied as described above at 6 days postinfection or at
the conclusion of the 10-day experiment.
Real-time PCR. Real-time PCR was used to detect the presence of viral DNA
in blood samples. DNA was extracted from buffy coats by using a QIAamp DNA
blood minikit (QIAGEN, Inc., Valencia, CA). Reaction mixes were prepared
and run with reagents from a SYBR green PCR master mix kit (Applied Bio-
systems) as recommended in a final volume of 25 l. The forward and reverse
primers were 5-GCCAAAAAAATTACCATATCAAGGTC-3 and 5-GAGC
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TGATCCAACATATACTATTGTGC-3 (500 nM), respectively. Sample tem-
plate (2.5 l) was added to each reaction in a SmartCycler 25-l reaction tube
(Cepheid, Sunnyvale, CA). Cycling conditions consisted of an initial denatur-
ation at 95 °C for 5 min, followed by an additional 45 amplification cycles (95°C
for 15 s, 58°C for 15 s, and 68°C for 60 s). Assays were run on a Cepheid
SmartCycler. Positive and negative controls were included with each set of
reactions.
Immunohistochemistry. Tissues were fixed in 10% neutral buffered formalin
for 48 h, embedded in paraffin, and sectioned onto SuperFrost Plus glass slides
(Fisher Scientific, Pittsburgh, PA). Sections were deparaffinized and rehydrated
according to standard methods, unmasked with Dako antigen retrieval solution
(DakoCytomation, Carpinteria, CA), and blocked with 2% normal horse serum
in PBS. Sections were sequentially incubated with polyclonal anti-SPPV serum
(1:10) overnight, biotinylated universal antibody (Vector Laboratories, Burlin-
FIG. 1. Characterization of a SPPV SPPV-019 gene deletion mutant, KLP, and its revertant, RvKLP. (A) Diagram of SPPV-019 domain
structure. (B) Diagram of SPPV-SA and recombinant viruses KLP, fsKLP, and RvKLP. The arrowhead in fsKLP indicates the position of the
stop codon. (C) PCR analysis of SPPV-SA, KLP, and RvKLP viral DNAs using primers specific for SPPV-019 or -glucuronidase (-GUS) gene
sequences. M, molecular markers; NTC, no template DNA.
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game, CA) for 1 h, ABC-AP (Vector Laboratories) for 30 min, and Vector Red
substrate solution (Vector Laboratories) for an additional 30 min. The slides
were counterstained with Mayer’s hematoxylin (Sigma-Aldrich, St. Louis, MO),
dehydrated, cleared, and mounted.
RESULTS
SPPV-019 encodes a kelch-like protein. The predicted 569-
amino-acid SPPV-019 protein is similar to kelch-like proteins
encoded by chordopoxviruses and metazoans (48). Present in
SPPV-019 are the domains conserved in other kelch-like pro-
teins, including an N-terminal BTB/POZ domain (Pfam 00651,
amino acids 15 to 116), a BACK domain (Pfam 07707, amino
acids 121 to 220), and a C-terminal kelch domain (amino acids
329 to 564) containing four kelch repeat motifs (Pfam 01344)
(Fig. 1A). The four intact kelch repeats are preceded by one
repeat that is incomplete and lacks the conserved tryptophan
residue of the 4 sheet within the predicted kelch domain
propeller blade structure (1). The BTB-BACK and the kelch-
repeat-containing domains are separated by a 109-amino-acid
linker region.
SPPV-019 is most similar to its orthologues in other chor-
dopoxviral genera, sharing 35 to 40% amino acid identity to
orthologues in genera closely related to CaPV (suipoxvirus,
yatapoxviruses, leporipoxviruses, and deerpox viruses) and 24
to 27% identity to orthopoxviral orthologues, including VACV
(strain Copenhagen) F3L. The orthologous nature of these
genes is further indicated by the conserved locus at which they
are located in all chordopoxviral genomes containing kelch-
like genes. This locus is in the left genomic region between the
dUTPase gene (orthopoxviruses, capripoxviruses, yatapoxvi-
ruses, and deerpox viruses) or myxoma virus m013L-like gene
(leporipoxviruses and suipoxvirus) and the ribonucleotide re-
ductase small subunit gene (61). Notably, SPPV-019 ortho-
logues represent the only kelch-like gene present in all poxvi-
ruses known to encode kelch-like proteins, making it the most
conserved poxviral kelch-like gene. Sequence conservation
among SPPV-019 orthologues is lowest in the linker region
separating the BACK domain from the kelch domain, a region
that contains a unique 40-amino-acid sequence in CaPV or-
thologues. SPPV-019 is less similar to paralogues in SPPV (18
to 24% amino acid identity to SPPV-144 and SPPV-151 over
their length), homologues in other poxvirus genera (including
VACV A55R and C2L [23 and 24% amino acid identity, re-
spectively]), and cellular kelch-like proteins.
Construction and analysis of SPPV SPPV-019 and SPPV-066
gene deletion mutants, KLP and TK, and the SPPV-019
revertant, RvKLP. To examine the role of SPPV-019 during
SPPV infection, an SPPV SPPV-019 gene deletion mutant,
KLP, and its revertant, RvKLP, were constructed. In KLP,
1,654 bp of the 1,706-bp SPPV-019 gene (98.5%) were deleted
and replaced with the 1,943-bp reporter gene cassette. In
RvKLP, KLP reporter gene sequences were replaced with
wild-type SPPV-019 sequences (Fig. 1B). An additional rever-
tant virus, fsKLP, containing a nonsense mutation at SPPV-019
amino acid position 231 was also constructed (Fig. 1B). As a
control for the generation of gene deletion mutants, an SPPV-
066 thymidine kinase gene deletion mutant (TK) was con-
structed by replacing the 5 307 bp of the SPPV-066 coding
sequence (531 bp) with the GUS cassette. Genomic DNA from
parental and recombinant viruses was analyzed by PCR. The
deleted SPPV-019 sequences were not detected in DNA prep-
arations prepared from KLP virus stocks but were amplified
from parental and revertant viral genomic DNAs. Reporter
gene sequences were detected only in the deletion mutant virus
(Fig. 1C). Similar results were obtained for TK (not shown).
DNA sequencing confirmed preservation of wild-type genomic
sequences flanking the deletion sites in recombinant viruses
and integrity of the wild-type SPPV-019 gene in RvKLP (not
shown).
SPPV-019 does not affect growth of SPPV in vitro. Growth
characteristics of KLP were compared to those of SPPV-SA
and RvKLP by infecting primary LK cell cultures (MOI  0.1)
and determining total virus titers at 24-h intervals for 5 days.
No significant differences in growth were observed between
these viruses, indicating that SPPV-019 is not essential for
SPPV growth in LK cells (Fig. 2A). As anticipated, the growth
characteristics of TK also were indistinguishable from those
of SPPV-SA (Fig. 2B). In addition, no differences in plaque
size or morphology were observed for KLP relative to the
parental virus (not shown).
SPPV-019 affects Ca2-independent cell adhesion in LK
cells. Of interest was the ability of KLP to affect Ca2-inde-
pendent cell adhesion in infected cultured cells, a phenotype
previously shown to be affected in VACV-infected cells by
deletion of C2L and A55R kelch-like genes (4, 47, 54). To
examine the ability of SPPV to affect cell adhesion in vitro and
FIG. 2. Growth characteristics of SPPV isolate SPPV-SA and re-
combinant SPPV viruses KLP, RvKLP (A), and TK (B) in primary
sheep LK cells. Cells were infected (MOI  0.1) with the appropriate
viruses and, at the indicated times postinfection, samples were col-
lected and titrated for virus yield. The data are the means and standard
errors of three independent experiments.
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the effect of SPPV-019 gene deletion on this phenotype, LK
cells were mock infected or infected with KLP, SPPV-SA, or
RvKLP for 24 h, followed by treatment of cultures with EDTA
(Fig. 3). Although 97% of mock-infected cells were rounded
and detached from the glass surface within 20 min of EDTA
treatment, ca. 50% of cells infected with SPPV-SA or RvKLP
remained adherent. This indicates that SPPV infection induces
Ca2-independent adhesion in LK cells. Cells infected with
KLP displayed a phenotype intermediate (88% of cells
rounded and detached) relative to SPPV-SA or RvKLP and
mock-infected cells, indicating that SPPV-019 contributes di-
rectly or indirectly to the Ca2-independent adhesion pheno-
type in LK cells.
SPPV-019 affects viral virulence in sheep. (i) Intranasal
inoculation. To examine the role of SPPV-019 on SPPV viru-
lence, Merino lambs were inoculated intranasally with 106
TCID50 of SPPV-SA, KLP, or TK (experiment 1) or SPPV-
SA, KLP, or RvKLP (experiment 2) and observed for clinical
signs of infection (Tables 1 and 2). In contrast to SPPV-SA and
RvKLP, where the combined mortality was 92%, all lambs
infected with KLP and TK survived the infection (Table 1).
Although lambs in all groups showed a fever response starting
on days 3 to 4 postinoculation, the mean body temperatures
were highest in lambs inoculated with SPPV-SA or RvKLP
(40.2°C), lowest in the TK group (39.3°C), and intermedi-
ate in KLP-infected lambs (39.7°C). Pyrexia persisted until
death in the SPPV-SA and RvKLP groups but ended after
approximately 1 or 2 weeks in TK and KLP groups, respec-
tively. All lambs inoculated with SPPV-SA (8 of 8 animals) or
RvKLP (5 of 5 animals) exhibited seromucous or purulent
nasal discharge. In contrast, only one KLP-infected lamb and
no TK-infected lambs exhibited nasal discharge (Table 1).
Differences in the development of skin lesions were ob-
served between experimental groups. Lambs inoculated with
SPPV-SA or RvKLP exhibited multiple skin lesions, which
appeared first in axillary, inguinal, and perineal regions and
eventually covered the entire body of most animals (Table 1).
Skin lesions progressed from macular to papular to nodular
forms (Fig. 4A). In contrast, of the eight lambs inoculated with
KLP, three failed to develop skin lesions, four exhibited a few
(	6) transient prepapular axillary and/or inguinal lesions (Fig.
4B), and only one animal exhibited papular skin lesions (ap-
proximately 15) (Table 1). No skin lesions were observed in
lambs inoculated with TK.
FIG. 3. Ca2-independent adhesion of LK cells infected with SPPV-SA, KLP, or RvKLP viruses. Monolayers of LK cells were infected (MOI 
10) with the indicated viruses or mock infected. At 24 hpi, cultures were treated with EDTA and photographs of cell monolayers under
phase-contrast microscopy were taken at 5-min intervals. The data were collected from three independent experiments, and the percent rounded
cells was calculated as described in Materials and Methods. The number 
 the standard deviation of rounded cells is shown.
TABLE 1. Survival and clinical response after intranasal inoculation of lambs with SPPV-SA, TK, KLP, or RvKLP virusesa
Expt and
virus
Survival Fever Nasal
discharge
(no. of
lambs/
total no.)
Skin lesions
No. of lambs
surviving/
total no.
Mean days to
death 
 SEM
Mean days to
onset 
 SEM (no.
of lambs with fever)
Duration (mean
no. of days 
 SEM)
Mean temp
(°C) 
 SEM
No. of lambs
with lesions/
total no.
Mean days to
onset 
 SEM
Expt 1
SPPV-SA 0/5 16.4 
 3.3 3.6 
 1.8 (5) 13.6 
 5.4 40.5 
 0.8 5/5 5/5 6.8 
 1.1
KLP 5/5 NA 4.6 
 1.9 (4) 13.0 
 1.2 39.7 
 0.5 0/5 4/5 6.0 
 1.6
TK 5/5 NA 3.6 
 2.2 (5) 6.6 
 3.4 39.4 
 0.4 0/5 0/5 NA
Expt 2
SPPV-SA 1/3 17.5 4.0 
 1.0 (3) 18.7 
 6.0 40.3 
 0.7 3/3 3/3 6.7 
 0.6
RvKLP 0/5 17.4 
 3.0 4.4 
 0.5 (5) 13.4 
 3.0 40.4 
 0.7 2/5 5/5 5.6 
 0.5
KLP 3/3 NA 4.3 
 0.6 (3) 15.7 
 2.5 39.7 
 0.7 1/3 1/3 7
a Lambs were inoculated with 106 TCID50 of the indicated viruses and examined for clinical signs of infection for 30 days. NA, not applicable.
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Although all lambs inoculated with SPPV-SA or RvKLP and
seven of eight lambs inoculated with KLP became viremic, the
appearance of KLP in blood (real-time PCR) was delayed ap-
proximately 1.5 days relative to SPPV-SA or RvKLP. Further, the
duration of viremia and maximum viremic titers in animals in-
fected with KLP were reduced (Table 2). No virus was detected
in blood collected from the TK group. Infectious virus was
detected in nasal secretions from all animals infected with
SPPV-SA or RvKLP. In contrast, only two of eight lambs inocu-
lated with KLP shed virus in nasal secretions, and the onset of
virus shedding was delayed and transient relative to the SPPV-SA
or RvKLP groups (Table 2). Lambs in the TK group did not
shed detectable virus in nasal secretions.
Upon postmortem examination, lambs inoculated with
SPPV-SA or RvKLP demonstrated tracheal ulcers (10 of 13
animals) and lesions in the rumen (6 of 13 animals), lungs (6 of
13 animals), and nasal turbinates (2 of 13 animals). In contrast,
lambs inoculated with KLP or TK lacked postmortem le-
sions, with the exception of a single tracheal ulcer in one
KLP-infected lamb. These results demonstrated that deletion
of SPPV-019 markedly attenuated SPPV in sheep after intra-
nasal inoculation.
(ii) Intradermal inoculation. To determine whether SPPV-
019-dependent attenuation is affected by inoculation route,
two groups of three lambs were intradermally inoculated in the
flank and in the inner side of the left thigh with 104 TCID50 of
FIG. 4. Skin lesions in lambs 8 days after intranasal (A and B) or intradermal (C and D) inoculation with SPPV-SA (A and C) or KLP (B
and D) viruses. Animals were inoculated with 106 (intranasal) or 104 (intradermal) TCID50. Panels A and B show the left axillary regions. In panels
C and D, arrows indicate inoculation sites in the inner side of the left thigh.
TABLE 2. Detection of SPPV in nasal secretions and blood after intranasal inoculation of lambs with SPPV-SA, KLP,
TK, or RvKLP virusa
Expt and
virus
Nasal secretions Viremia
No. of lambs
shedding
virus/total no.
inoculated
Mean days
to onset
postinoculation 

SEM
Duration (mean no.
of days 
 SEM)
Mean days to
onset 
 SEM
(no. of viremic lambs)
Duration (mean no.
of days 
 SEM)
Maximum viremia
(log10 TCID50/
ml) 
 SEM
Expt 1
SPPV-SA 5/5 8.4 
 1.7 8.0 
 2.0 5.6 
 0.9 (5) 10.8 
 3.0 ND
KLP 0/5 NA NA 7.0 
 2.0 (4) 3.5 
 1.0 ND
TK 0/5 NA NA ND ND ND
Expt 2
SPPV-SA 3/3 3.7 
 0.6 11.0 
 1.0 4.0 
 0.0 (3) 7.7 
 0.6 4.7 
 0.5
RvKLP 5/5 4.0 
 0.0 10.0 
 1.4 3.8 
 0.4 (5) 7.8 
 0.4 4.2 
 0.9
KLP 2/3 10.5 6.5 5.7 
 1.5 (3) 5.7 
 1.5 2.8 
 0.5
a Lambs were inoculated with 106 TCID50 of the indicated viruses. Virus detection in secretions and virus titers in buffy coats was performed with LK cell cultures.
Virus detection in buffy coats was performed using real-time PCR. NA, not applicable; ND, not done.
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SPPV-SA or KLP and euthanized and necropsied at either 6
or 10 days postinoculation (Table 3). All inoculated lambs
developed large, raised, erythematous lesions at the inocula-
tion sites, although one lamb in the KLP group developed a
lesion in the flank but not in the thigh. Although lesion size at
thigh inoculation sites tended to be larger in SPPV-SA- than in
KLP-infected lambs, differences between groups were not
significant. Lambs inoculated with SPPV-SA developed high
fever (40.5°C) and generalized skin lesions (Fig. 4C),
whereas lambs inoculated with KLP showed mild fever and
either no secondary skin lesions (Fig. 4D) or transient pre-
papular lesions (Table 3). Detection of viral DNA in blood was
delayed by 2 to 4 days in KLP-infected animals relative to
those infected with SPPV-SA (Table 3). Lambs infected with
SPPV-SA began shedding virus in nasal secretions by day 10,
while lambs infected with KLP did not shed detectable virus.
Postmortem examination revealed multiple lesions in the lungs
and rumina of lambs inoculated with SPPV-SA, whereas only
one of the lambs inoculated with KLP showed a few scattered
focal lesions in these organs. Tissue samples from the inocu-
lation sites and draining lymph nodes, axillary skin, and lungs
were collected for virus titration. Although virus was detected
in the skin and lymph nodes from all lambs infected with
SPPV-SA, no virus was detected in lambs inoculated with
KLP other than at the inoculation sites (Table 3). On day 10,
no significant difference in virus titer was observed from skin
inoculated with SPPV-SA or KLP (Table 3). Furthermore,
histology and immunohistochemistry of skin lesions at inocu-
lation sites exhibited no differences in pathology or viral anti-
gen distribution between groups (not shown). These results
indicate that KLP, while replicating at the site of intradermal
inoculation, is restricted in its ability to disseminate and cause
generalized disease.
As an additional control for the KLP phenotype, fsKLP, a
virus maintaining SPPV-019 coding sequences but harboring a
nonsense mutation at SPPV-019 amino acid position 231, was
intradermally inoculated into two lambs as described above.
Only one of the two lambs showed a transient fever response
(40°C) that persisted for 3 days. Similar to KLP, primary
lesions at inoculation sites were observed, but secondary skin
lesions were absent.
DISCUSSION
We have shown here that an SPPV kelch-like gene, SPPV-
019, affects viral virulence in sheep. A recombinant virus with
an SPPV-019 deletion, KLP, was markedly attenuated after
virus inoculation by the intranasal or intradermal routes (Ta-
bles 1, 2, and 3). Attenuation of KLP relative to parental
(SPPV-SA) or revertant (RvKLP) viruses was demonstrated by
100% lamb survival, decreased fever response and nasal dis-
charge, marked reduction in number and development of skin
and internal lesions, reduced viremia titers and duration of
viremia, and reduced virus shedding. The observed attenuation
of KLP in the natural SPPV host species and use of the
natural route of infection indicates that SPPV-019 is a bona
TABLE 3. Clinical signs, lesions at necropsy, and virus titers after intradermal inoculation of lambs with SPPV-SA or KLP virusesa
Parameter
6 dpi 10 dpi
SPPV-SA
(animal 14)
KLP
(animal 20)
SPPV-SA KLP
Animal 15 Animal 17 Animal 18 Animal 19
Clinical
Lesion size at inoculation siteb (mm)
Flank 32 29 53 30 40 33
Thigh 60 30.5 47 47 0 32
Maximum temp (°C) (no. of days) 39.4 (1) 39.7 (1) 40.8 (7–10) 40.8 (5, 9) 40.1 (7–9) 39.8 (7)
NISc skin lesions (days) Papula (5–6) No lesions Papula (5–10) Papula (5–10) No lesions Prepapula (6–8)
Virus sheddingd (day) Negative Negative Positive (10) Positive (10) Negative Negative
Postmortem lesions
NISc skin Generalized None Generalized Generalized None None
Lung Multiple None Multiple Multiple None Few
Rumen Multiple None Multiple Multiple None Few
Virus titere (mean 
 SEM)
Inoculation site
Flank 4.8 
 0.0 3.5 
 0.3 7.8 
 0.0 4.8 
 0.5 6.8 
 0.5 5.8 
 0.0
Thigh 7.4 
 0.3 5.8 
 0.0 6.5 
 0.3 7.5 
 0.3 0 5.8 
 0.0
Perilumbar LN 4.8 
 0.0 0 4.5 
 0.5 4.1 
 0.3 0 0
Inguinal LN 6.1 
 0.3 0 3.8 
 0.0 3.8 
 0.0 0 0
Prescapular LN NA NA 3.1 
 0.3 3.1 
 0.3 0 0
Lung NA NA 0 0 0 0
Viremiaf (days detected) (CT) 4–6 (29.5) 6 (42.5) 4–10 (30.4) 4–10 (28.3) 8 (41.6) 8–10 (32.2)
a Lambs were inoculated with 104 TCID50 SPPV-SA or KLP or mock infected with PBS and then sacrificed at 6 or 10 days postinoculation (dpi).
b At time of necropsy.
c NIS, noninoculation site.
d Buccal swabs were tested for the presence of virus by virus isolation.
e Presented as the TCID50/mg of tissue 
 SEM. LN, lymph node.
f That is, the viral genomic DNA in buffy coats as detected by real-time PCR, including the average threshold cycle (CT) in parentheses.
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fide virulence determinant for SPPV. This represents the first
attenuation of virulent SPPV or any other pathogenic CaPV by
engineered gene deletion.
The marked decrease in lesion number and the limited pro-
gression of lesion development exhibited by lambs intranasally
or intradermally inoculated with KLP (Tables 1 and 3) may
be partially explained by the reduced magnitude and duration
of viremia (Tables 2 and 3). In lambs inoculated by the intra-
dermal route, KLP failed to spread to lymph nodes, and
secondary skin and lung lesions were less numerous and less
pronounced than in lambs inoculated with wild-type virus (Ta-
ble 3). However, lesion size and KLP skin titers at dermal
inoculation sites were comparable to those of SPPV-SA. Over-
all, these data suggest that KLP is restricted in its ability to
spread to secondary sites of infection.
Growth characteristics of KLP in primary sheep cells (LK)
were indistinguishable from those of SPPV-SA or RvKLP (Fig.
2), indicating that SPPV-019 is not essential for virus growth in
these cells and suggesting that, similar to kelch-like genes
present in orthopoxviruses, SPPV-019 is dispensable for growth
in vitro (36, 37, 45). In CPXV, deletion of kelch-like genes
D11L, G3L, C18L, or A57R did not affect virus growth in a
number of cell lines; however, simultaneous deletion of three
or four of these genes delayed virus replication in certain cell
lines, suggesting an additive or gene dosage effect for kelch-
like genes in some aspects of host range (36). Whether an
additive effect would be seen with double or triple SPPV kelch-
like gene deletion mutants remains to be determined.
The present study demonstrates that deletion of a single
viral kelch-like gene from SPPV leads to marked attenuation
of virus in the natural host. Previous studies deleting single
kelch-like genes in CPXV and VACV failed to reduce viral
virulence in mice. Further, CPXV double kelch-like gene
knockouts in mice caused disease indistinguishable from that
of wild-type CPXV, and a significant decrease in virus viru-
lence was observed only with quadruple kelch-like gene dele-
tion mutants (36). VACV with C2L or A55R gene deletions
exhibited no difference in weight loss or mortality relative to
parental virus after intranasal inoculation of mice (4, 47). How-
ever, in an intradermal mouse model, infection with one of
these two viruses with deletions in one of these two genes
resulted in lesions that were larger (A55R and C2L), took
longer to heal, and contained more abundant cell infiltrates
(C2L) than those observed for parental and revertant vi-
ruses, suggesting that C2L and A55R function by limiting the
intradermal pathology of VACV, perhaps by modulating
inflammatory responses (4, 47).
The range of phenotypes observed among SPPV-019 single
gene and orthopoxviral kelch-like gene deletion studies may be
explained by functional differences of specific poxviral kelch-
like proteins individually or within the context of the viral
genotype, the nature of the host used, or both. Although all
encode kelch-like proteins, SPPV-019, VACV C2L, and
VACV A55R are distinct genes. The lack of complementation
between VACV C2L and A55R in vitro and the slight pheno-
typic differences between the C2L and A55R gene deletion
mutants in mice support functional differences in these genes.
In addition, SPPV, VACV, and CPXV genomes contain dis-
tinct kelch-like genes and overall gene complements that may
influence the effect of individual kelch-like proteins. Finally,
the limited host range of SPPV and its virulence in sheep
relative to VACV and CPXV in mice suggest that sheeppox
may be a useful and appropriate natural host model to func-
tionally determine specific roles of virulence and host range
determinants in disease (17, 39).
The function(s) of poxviral kelch-like proteins is unknown.
Compared to wild-type VACV, infection of cells with VACV
C2L or A55R gene knockouts resulted in altered plaque mor-
phology and a reduction in the formation of cellular projec-
tions and Ca2-independent cell adhesion in vitro, indicating
that C2L and A55R may play a role in promoting Ca2-inde-
pendent cell adhesion and cellular projection formation (4, 47,
54). Similar to VACV C2L and A55R deletion mutants, KLP-
infected cells did exhibit a reproducible 40% reduction in
Ca2-independent cell adhesion (Fig. 3); however, no obvious
differences in plaque morphology were observed between
SPPV-SA and KLP-infected cultures, and no cellular projec-
tions were observed in any SPPV-infected cells (not shown).
How SPPV-019 may specifically affect cellular adhesion or
whether a cell adhesion function is involved in failure of KLP
to spread to secondary sites within the host have yet to be
determined.
Poxviral kelch-like proteins conceivably perform a range of
functions during infection, potentially through interaction with
cytoskeleton or through protein ubiquitination. The effect of
SPPV-019 on cellular adhesion is consistent with roles of cel-
lular kelch-like proteins in cell attachment and cytoskeletal
dynamics (1, 27, 29, 49, 56). The cytoskeleton has also been
shown to affect critical processes during VACV infection; how-
ever, the phenotypes of KLP described here suggest that
functions affected by potential SPPV019-cytoskeletal interac-
tion are distinct and perhaps more host range related (10, 13,
28, 40, 53). Kelch-like proteins have also been shown to func-
tion as substrate adaptor molecules for Cul3-based E3 ubiq-
uitin ligase complexes (14, 20, 23, 35, 38, 46). Other poxviral
genes have been predicted to encode ubiquitin ligase-related
proteins, and poxvirus-encoded ubiquitin ligases have been
shown to target host proteins and affect viral virulence and host
range, thus making attractive an E3 substrate adapter role for
virally encoded kelch-like proteins (3, 25, 41, 42). SPPV-019
could also affect cell attachment through an E3-adapter pro-
tein function, since ubiquitination pathways have been shown
to affect cell attachment and cytoskeletal dynamics (19, 30, 64).
The precise mechanism(s) through which SPPV-019 or other
poxviral kelch-like proteins affect virulence requires further
investigation.
SPPV-019 orthologues in vaccine strains GTPV G20 and
LSDV Neethling contain frameshift mutations at positions 231
and 124, respectively, suggesting that SPPV-019 orthologues
affect CaPV virulence (31, 60). The results here with SPPV
further support the hypothesis that mutation of SPPV-019 or-
thologues contributes to the attenuated phenotypes of these
vaccines. Similar to GTPV G20, the fsKLP mutant generated
here harbors a nonsense mutation in the region separating the
BTB and BACK domains from the kelch repeat-containing
domain. Interestingly, fsKLP also was attenuated after intrad-
ermal virus inoculation of lambs, suggesting that a complete
SPPV-019 protein is necessary for virus virulence.
Infection with TK did not affect SPPV replication in tissue
culture but resulted in an even more attenuated phenotype
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than KLP in vivo. Lambs intranasally inoculated with TK
did not shed detectable virus in nasal secretions and, with the
exception of a transient, low-magnitude fever response, did not
develop signs of disease (Tables 1 and 2), indicating that SPPV-
066 is an SPPV virulence factor in sheep. Preliminary studies
using the intradermal route of infection showed that, unlike
KLP, TK fails to induce a lesion at the inoculation site,
suggesting that viral TK is important for virus growth in the
skin (not shown). An important role for viral TK in pathogen-
esis has been previously reported with other large DNA vi-
ruses, including VACV (8, 59), African swine fever virus (43),
and herpes simplex virus (12). The TK locus has been used as
a site of insertion for foreign viral genes during construction of
CaPV vaccine expression vectors; however, these recombi-
nants were derived from previously attenuated CaPV, and the
effect of TK deletion on viral virulence has not been reported
(5, 15, 50–52).
Sheeppox is of major economic significance in the develop-
ing world, and vaccination is the most important disease con-
trol strategy in areas of endemicity. Attenuated live vaccines,
obtained through serial passage of SPPV in tissue culture, have
been used with variable success. Problems associated with
these vaccines include variable levels and duration of protec-
tion, lack of vaccine virus characterization, and safety issues
(6). Studies of SPPV virulence determinants in the natural host
may be useful to better define mechanisms underlying poxviral
pathogenesis and for engineering novel vaccines with improved
safety and efficacy and of greater utility.
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ADDENDUM
Since completion of the work described here, deletion of the
SPPV-019 orthologue in VACV (F3L) has been reported to
result in modest but significant reduction in lesion size and
alteration of infiltrating immune cell populations in a mouse
intradermal model of VACV infection, a finding suggestive of
an effect on innate immune responses (18a). Whether a similar
effect on immune response contributes to the attenuated phe-
notype of the SPPV-019 gene deletion mutant reported here
remains to be determined.
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